Quality of Life Among Survivors of Hodgkin Lymphoma

A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin Lymphoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00598728

Enrollment

255

Registered

2008-01-22

Start date

2005-05-31

Completion date

2016-04-30

Last updated

2016-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hodgkin's Disease

Keywords

Survivors, Quality of Life

Brief summary

The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.

Interventions

BEHAVIORALQuality of Life Questionaires

A patient questionnaire, which includes questions on medical morbidities and QOL, will be mailed to participants.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Biopsy-proven HL Participation in IRB-approved protocols for the first-line treatment of HL between 1975-2000 (IRB #75-104, #75-103, #79-17, #81-103, #90-44, #91-69). * English speaking

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
To evaluate the prevalence of late medical complications among HL survivors	conclusion of study

Secondary

Measure	Time frame
To study the effect of HL and its treatment on QOL among HL survivors.	conclusion of study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026